Jim Simons Onconova Therapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Onconova Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 268,194 shares of ONTX stock, worth $152,870. This represents 0.0% of its overall portfolio holdings.
Number of Shares
268,194
Previous 198,841
34.88%
Holding current value
$152,870
Previous $148,000
83.11%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ONTX
# of Institutions
27Shares Held
1.71MCall Options Held
2.6KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA709KShares$403,9120.0% of portfolio
-
Black Rock Inc. New York, NY249KShares$141,8600.0% of portfolio
-
Geode Capital Management, LLC Boston, MA193KShares$109,9290.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny73.1KShares$41,6470.0% of portfolio
-
State Street Corp Boston, MA52.8KShares$30,0900.0% of portfolio
About Onconova Therapeutics, Inc.
- Ticker ONTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,895,600
- Market Cap $11.9M
- Description
- Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...